Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

H. Lundbeck A/S🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 12, 2024
Approval ID: 09a85d2b193ade05
Company: H. Lundbeck A/S
Type: Standard

Approval Details

Approval Id: 09a85d2b193ade05
Drug Cima Aemps Name: BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 113891028IP
Holder Company Name: H. Lundbeck A/S
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/h-lundbeck-a-s
Authorization Date: 2024-07-12
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: H. Lundbeck A/S
Company Detail Path: /organization/h-lundbeck-a-s

Company Information

Pharmaceutical Company Name: H. Lundbeck A/S
Name En: H. Lundbeck A/S
Country Name: Denmark
City Name: valby,hovedstaden,country_dk
Address: Ottiliavej 9
Website: https://www.lundbeck.com

Active Ingredients

VORTIOXETINA HIDROBROMURO

20 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 12, 2024

Approval ID

09a85d2b193ade05

Type

Standard

Back to CIMA-AEMPS Approvals

BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details